The gut microbiota can be involved in the development of colorectal and liver cancer. The unveiling of the underlying processes provides promising starting points for creating novel diagnostic and therapeutic measures. This was demonstrated by the findings Prof. Robert F. Schwabe (Columbia University, New York, USA) and Dr. Peer Bork (University of Heidelberg, Germany) presented at the Gut Microbiota for Health World Summit in Barcelona (March 14-15, 2015).
- Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade
- A synthetic consortium of 100 gut commensals modulates the composition and function in a colon model of the microbiome of elderly subjects
- ‘Multi-kingdom dialogue’ between internal, external microbiota
- Gut microbiota-derived short-chain fatty acids promote prostate cancer growth via IGF-1 signaling
- Diet alters entero-mammary signaling to regulate the breast microbiome and tumorigenesis